# Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

> **NCT05193396** · PHASE4 · RECRUITING · sponsor: **Marianne Andersen** · enrollment: 100 (estimated)

## Conditions studied

- Adrenal Insufficiency
- Polymyalgia Rheumatica (PMR)
- Giant Cell Arteritis (GCA)

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05193396
- **Lead sponsor:** Marianne Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193396, "Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05193396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*